Literature DB >> 31763936

The impact of flushing with pre-filled saline syringes on the incidence of peripheral venous catheter failure: A quasi-experimental study.

Patrick Saliba1, Guillermo Cuervo1,2, Ana Hornero1, Gabriella De Carli3, Alessandra Marani3, Vincenzo Puro3, Ana Felisa López4, Simona Iftimie4, Antoni Castro4, Vicens Diaz-Brito Fernandez5, Maria Carmen Alvarez Moya5, Cristina Jimenez De La Rosa5, José Martínez-Sánchez6, Emilio Jimenez1, Jordi Carratalà1,2, Miquel Pujol1,2.   

Abstract

BACKGROUND: Short peripheral venous catheters are one of the most frequently used devices in hospitals. Peripheral venous catheter failure, defined as the unscheduled dysfunction of peripheral venous catheter, is common and frequently entails a new invasive procedure. Flushing the catheter maintains patency and could prolong peripheral venous catheter dwell time. The introduction of pre-filled saline flushing syringes as compared to manually filled saline flushing syringes could facilitate the frequency of catheter flushing, and subsequently it could reduce peripheral venous catheter failure rate.
OBJECTIVE: To demonstrate differences in overall peripheral venous catheter failure rates before and after the introduction of pre-filled saline flushing syringes and to assess the risk factors for peripheral venous catheter failure.
METHODS: Quasi-experimental design, before-and-after intervention study. Intervention: introduction of pre-filled saline syringes for flushing. Multicenter study conducted in medical and surgical wards of three European hospitals during a 9-month period (4 months pre-intervention, 5 months intervention). A multivariate Cox proportional model was used to identify factors associated with the occurrence of peripheral venous catheter failure.
RESULTS: Data from 3853 peripheral venous catheters in 1915 patients were analyzed. Compared to pre-intervention period, a significant decrease in peripheral venous catheter failure rate was observed in the intervention period (57% vs 43.4%, p < 0.001). Independent factors associated with peripheral venous catheter failure were as follows: Charlson score ⩾4 (hazard ratio: 1.648; 95% confidence interval: 1.069-2.527), days of hospital stay ⩾10 (hazard ratio: 1.468; 95% confidence interval: 1.172-1.837), and catheter "D" (hazard ratio: 1.758; 95% confidence interval: 1.058-2.919).
CONCLUSION: The use of pre-filled saline syringes significantly reduced peripheral venous catheter failure and increased catheter dwell time. Thus, it is important to reinforce the use of the pre-filled syringes for flushing to reduce the incidence of peripheral venous catheters' failure.

Entities:  

Keywords:  CRBSI; PVC; PVC adverse events; PVC failure; Peripheral venous catheter; flushing

Mesh:

Substances:

Year:  2019        PMID: 31763936     DOI: 10.1177/1129729819888423

Source DB:  PubMed          Journal:  J Vasc Access        ISSN: 1129-7298            Impact factor:   2.283


  3 in total

1.  The flushing procedure in nursing practices: A cross-sectional study with Portuguese and Brazilian nurses.

Authors:  Pedro Parreira; Ricardo Vicente; Rafael A Bernardes; Liliana B Sousa; Beatriz Serambeque; Paulo Costa; Luciene M Braga; Lisete Mónico; Anabela Salgueiro-Oliveira
Journal:  Heliyon       Date:  2020-08-08

2.  Nurses' Involvement in the Development and Usability Assessment of an Innovative Peripheral Intravenous Catheterisation Pack: A Mix-Method Study.

Authors:  Paulo Santos-Costa; Mariana Alves; Carolina Sousa; Liliana B Sousa; Filipe Paiva-Santos; Rafael A Bernardes; Filipa Ventura; Anabela Salgueiro-Oliveira; Pedro Parreira; Margarida Vieira; João Graveto
Journal:  Int J Environ Res Public Health       Date:  2022-09-05       Impact factor: 4.614

3.  Implementation and evaluation of short peripheral intravenous catheter flushing guidelines: a stepped wedge cluster randomised trial.

Authors:  Samantha Keogh; Caroline Shelverton; Julie Flynn; Gabor Mihala; Saira Mathew; Karen M Davies; Nicole Marsh; Claire M Rickard
Journal:  BMC Med       Date:  2020-09-30       Impact factor: 8.775

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.